These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 10929963)
1. The effect of tamoxifen on the endometrium, serum lipids and hypothalamus pituitary axis in the postmenopausal breast cancer patients. Kavak ZN; Binöz S; Ceyhan N; Pekin S Acta Obstet Gynecol Scand; 2000 Jul; 79(7):604-7. PubMed ID: 10929963 [TBL] [Abstract][Full Text] [Related]
2. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF; Lin HH; Torng PL; Huang SC Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [TBL] [Abstract][Full Text] [Related]
3. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921 [TBL] [Abstract][Full Text] [Related]
4. Transvaginal endometrial sonography in postmenopausal women taking tamoxifen. Tesoro MR; Borgida AF; MacLaurin NA; Asuncion CM Obstet Gynecol; 1999 Mar; 93(3):363-6. PubMed ID: 10074980 [TBL] [Abstract][Full Text] [Related]
5. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875 [TBL] [Abstract][Full Text] [Related]
6. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913 [TBL] [Abstract][Full Text] [Related]
7. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
8. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294 [TBL] [Abstract][Full Text] [Related]
10. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen. Elhelw B; Ghorab MN; Farrag SH Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051 [TBL] [Abstract][Full Text] [Related]
11. The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Markovitch O; Tepper R; Fishman A; Shapira J; Aviram R; Cohen I Gynecol Oncol; 2004 Dec; 95(3):456-62. PubMed ID: 15581946 [TBL] [Abstract][Full Text] [Related]
12. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen. Sinawat S; Chiyabutra T; Kleabkaew P Asian Pac J Cancer Prev; 2003; 4(4):327-30. PubMed ID: 14728591 [TBL] [Abstract][Full Text] [Related]
13. Long-term "protective" effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients. Markovitch O; Tepper R; Fishman A; Aviram R; Cohen I Breast Cancer Res Treat; 2009 Jan; 113(2):321-6. PubMed ID: 18297393 [TBL] [Abstract][Full Text] [Related]
14. [Changes in the endometrium in treatment of breast carcinoma with tamoxifen]. Reslová T; Tosner J; Vávrová I; Resl M Ceska Gynekol; 1997 Oct; 62(5):277-9. PubMed ID: 9600168 [TBL] [Abstract][Full Text] [Related]
15. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma. Juneja M; Jose R; Kekre AN; Viswanathan F; Seshadri L Int J Gynaecol Obstet; 2002 Mar; 76(3):279-84. PubMed ID: 11880131 [TBL] [Abstract][Full Text] [Related]
17. Indication of hysteroscopy in tamoxifen treated breast cancer patients. Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527 [TBL] [Abstract][Full Text] [Related]
18. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology. Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer. Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960 [TBL] [Abstract][Full Text] [Related]
20. Long-term transvaginal ultrasonographic endometrial follow-up in postmenopausal breast cancer patients with tamoxifen treatment. Nahari C; Tepper R; Beyth Y; Flex D; Figer A; Cohen I Gynecol Oncol; 1999 Aug; 74(2):222-6. PubMed ID: 10419735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]